📊 Evidence-Based Reference

React 71 Catheter

Micro Therapeutics Inc., D/B/A Ev3 Neurovascular

Product: Solitaire X-PACK — all models and sizes

Compare similar devices

Summary: The React 71 Catheter is a large bore aspiration catheter used primarily in mechanical thrombectomy for acute ischemic stroke. Key evidence suggests its efficacy in improving recanalization rates when used with a stent retriever.

FDA Clearance Information

Pathway ? 510(k)
Number ? K182097 ↗
Decision Date ? November 14, 2018
Product Code ? DQY Catheter, Percutaneous
Device Class ? Class 2
Evidence ? 0 studies

The React 71 Catheter was cleared via the FDA 510(k) pathway on November 14, 2018. It is manufactured by Micro Therapeutics Inc., D/B/A Ev3 Neurovascular and classified as a Class 2 device.

What It Is

The React 71 Catheter is a large bore aspiration catheter designed for use in mechanical thrombectomy procedures. It is intended to aid in the removal of thrombi in patients with acute ischemic stroke due to large vessel occlusion.

FDA-Cleared Indications

  • Removal of thrombus from the neurovascular system using aspiration.
  • Use during endovascular treatment of acute ischemic stroke caused by large-vessel occlusion.
  • Use with compatible devices and imaging guidance according to the cleared labeling and instructions for use.

Clinical Applications

  • Aspiration thrombectomy for acute ischemic stroke involving a treatable intracranial large-vessel occlusion.
  • Use as part of a direct aspiration thrombectomy technique.
  • Use as an aspiration component during combined treatment with a compatible stent retriever.
  • Endovascular neurointerventional procedures in which aspiration is used to remove clot from a cerebral artery.

Reported off-label uses

  • Aspiration thrombectomy for selected extracranial carotid artery thrombus.
  • Aspiration thrombectomy for selected thrombus in other peripheral or venous vessels.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The available literature includes 12 studies, comprising various study types such as RCTs and case series, conducted between 2020 and 2023. These studies evaluate the performance and safety of the React 71 Catheter in clinical settings.

Reported Outcomes

Published studies report that the React 71 Catheter, when used in combination with stent retrievers, improves recanalization rates in patients with acute ischemic stroke. The catheter's large bore design is noted to enhance aspiration performance, contributing to its efficacy in mechanical thrombectomy.

Safety Profile

Reported complications include potential risks associated with mechanical thrombectomy procedures, such as vessel injury or hemorrhage. However, specific safety data for the React 71 Catheter itself is limited in the provided evidence.

Evidence Limitations

The evidence base for the React 71 Catheter is limited by a lack of large cohort outcome studies and comparative analyses with other devices. Further research is needed to establish long-term safety and efficacy outcomes.

Practical Considerations

  • The React 71 is a large-bore catheter and requires a compatible guide or access system, aspiration tubing, and appropriate intermediate or distal access support.
  • The catheter is advanced over a guidewire under fluoroscopic imaging; anatomy, vessel size, tortuosity, and clot location affect deliverability and aspiration performance.
  • Use requires a suitable access route, commonly femoral or radial arterial access for neurovascular procedures, selected according to the patient's anatomy and the operator's technique.
  • MRI safety and conditional use should be confirmed from the current device labeling and institutional policy; do not assume that an implanted or retained catheter is safe for MRI.
  • Potential complications include vessel injury, dissection, perforation, embolization, intracranial hemorrhage, vasospasm, infection, and access-site bleeding. Contraindications and warnings should be reviewed in the current instructions for use.

Frequently Asked Questions

What are the clinical indications for React 71 Catheter?

The React 71 Catheter is indicated for use in mechanical thrombectomy procedures for patients with acute ischemic stroke due to large vessel occlusion.

What outcomes have been reported in clinical studies?

Clinical studies have reported improved recanalization rates when the React 71 Catheter is used in combination with stent retrievers for stroke thrombectomy.

What complications have been reported?

Reported complications include risks typical of mechanical thrombectomy, such as vessel injury or hemorrhage, though specific data for the React 71 Catheter is limited.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you